Clinical Trials
17 trialsNCT00588770 2026-05-29
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT01711541 2023-06-07
Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00408694 2018-01-30
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00004094 2014-01-06
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00003576 2013-12-19
Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003637 2013-12-19
Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002747 2013-09-20
Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00004097 2013-09-20
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00002476 2013-08-02
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00004089 2013-07-10
Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00006106 2013-07-10
ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1 Withdrawn
NCT00004901 2013-06-26
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00002888 2013-06-21
Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00093665 2013-05-15
Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00023959 2013-02-07
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00004865 2009-03-09
Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
National Cancer Institute (NCI)
Phase 2 Completed
NCT00004164 2009-02-09
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
National Cancer Institute (NCI)
Phase 2 Unknown